The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populations
COPD was an independent risk factor for MACE in CKM populations. ICS did not attenuate MACE amongst CKM-COPD groups. Incident COPD was associated with MACE in CKD, and being at risk of COPD was associated with MACE in CKD, MACE history, and Age65 + cohorts.
Authors
- Emily L. Graul (ORCID: https://orcid.org/0000-0003-4717-0907)
- Upasana Tayal (ORCID: https://orcid.org/0000-0003-2262-4626)
- Constantinos Kallis (ORCID: https://orcid.org/0000-0003-0866-5421)
- Anne E Ioannides (ORCID: https://orcid.org/0000-0001-8611-4751)
- Hana Mullerova
- Jennifer K. Quint
Institutions
- Emory University (US)
- The George Institute for Global Health (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Harefield Hospital (GB)
- London Biofoundry (GB)
- AstraZeneca (France) (FR)
- AstraZeneca (Switzerland) (CH)
- Imperial College London (GB)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1186/s12916-026-04754-7
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00